47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
61.90.Z - Activities in other telecommunications fields
82.92.Z - Packaging activities
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,3 | 2 | 2,2 | 7,5 |
EBITDA | 2,3 | 2,1 | 2,2 | 7 |
Short time liabilities | 1,7 | 1,3 | 1,8 | 31 |
Equity capital | 2,1 | 2,3 | 2,7 | 17,3 |
Operating profit (EBIT) | 2,3 | 2 | 2,2 | 7,5 |
Assets | 3,9 | 3,8 | 4,5 | 18,3 |
Net profit (loss) | 2,3 | 2 | 2,2 | 7,5 |
Cash | 0,8 | 0,6 | 0,6 | 13,7 |
Net income from sale | 26,8 | 29 | 32,2 | 10,9 |
Liabilities and provisions for liabilities | 1,8 | 1,5 | 1,8 | 19,9 |
Working assets | 3,5 | 3,5 | 4,2 | 21,6 |
Depreciation | 0,1 | 0,1 | 0,1 | -11,9 |
% | % | % | p.p. | |
Profitability of capital | 108,1 | 87,8 | 80,4 | -7,4 |
Equity capital to total assets | 53,7 | 61,4 | 60,9 | -0,5 |
Gross profit margin | 8,5 | 7 | 6,8 | -0,2 |
EBITDA Margin | 8,8 | 7,3 | 7 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 17 | 20 | 3 |
Current financial liquidity indicator | 2.087252378463745 | 2.5879933834075928 | 2.4015865325927734 | -0,2 |
Net dept to EBITDA | -0.17544429004192352 | -0.2049226313829422 | -0.2808369994163513 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane